About Ark

Making medicine at
the speed of AI

AI is changing how drugs are discovered. Making them still depends on slow, expensive trial and error, one experiment and one batch at a time. Ark builds the world model for biomanufacturing, so new medicines reach more patients, sooner.

Team

Built for the hardest problems in bioprocess. Ark is a small team of scientists, modelers and software engineers, most of us with PhDs, building AI that predicts how living cells behave at industrial scale. Pharma brings us the problems it can’t solve in-house.

Yossi Quint

Co-Founder & CEO

Yossi began his career as a quantitative researcher at Two Sigma, where he saw how modeling changed the financial industry. He started Ark to bring that power to the step where cells become medicine.

Nick Austin

Head of Modeling

Nick leads Ark’s modeling team and the work that combines physics with AI at the core of the platform. He holds a PhD in optimization from Carnegie Mellon.

Robert Seares

Head of Software

Robert leads the engineering behind Ark’s platform, from the simulation engine to the agents that put it to work.

Our team has worked and studied at
Advisors

Zheng Huang

Co-Founder, Ark Biotech; Former Director of MSAT, Sanofi

Ariel Katz

Founder & CEO, H1

Prof. Abba M. Krieger

Robert Steinberg Professor Emeritus of Statistics and Data Science, Wharton

Prof. Cleo Kontoravdi

Professor of Biological Systems Engineering, Imperial College

Prof. Richard Allmendinger

Professor of Applied AI, The University of Manchester

Robert Kiss, PhD

Distinguished Engineer and Former Senior Director of BioProcess Development, Genentech

Rahul Singhvi

Co-Founder, National Resilience

Put the world model to work on your process

Run your next program

the new way.

Give your plant an

army of agents.